Arkolith/Insider Trading/NAUT/Form 4

Mallick Parag

Chief Scientist, Director, 10% OwnerNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed May 12, 2025
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2025Buy(P)2K$0.73$1K20.5M
May 8, 2025Buy(P)12K$0.73$9K20.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-25-000049) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML